ABL Bio
298380.KQ
55.58 USD
-0.14
-0.25%
a
Overview
Last close
55.58 usd
Market cap
2.70B usd
52 week high
64.68 usd
52 week low
15.54 usd
Target price
61.48 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
137.3442
Price/Book Value
26.8359
Enterprise Value
2.66B usd
EV/Revenue
133.8587
EV/EBITDA
-32.1061
Key financials
Revenue TTM
19.89M usd
Gross Profit TTM
19.85M usd
EBITDA TTM
-51.68M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
142.99M usd
Net debt
13.42M usd
About
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio Inc.is headquartered in Seongnam-si, South Korea.
- Symbol298380.KQ
- ExchangeKQ
- IsinKR7298380007
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CEODr. Sang Hoon Lee Ph.D.
- HeadquarterSeongnam-si
- Web sitehttps://www.ablbio.com
